02Jun 2023
Reprogramming autologous cells to treat OA

Reprogramming autologous cells to treat OA

A promising autologous-cell-based therapy has been developed to address osteoarthritis (OA) by targeting the synovial microenvironment. This innovative treatment redirects the pathological processes in the affected joints, facilitating the repair of articular cartilage. With over 500 million people worldwide affected by OA, this therapy holds significant potential as an effective treatment option.

  • #rheumatology

Like

Save

Share